PHADE
Research type
Research Study
Full title
A PERFORMANCE EVALUATION OF THE LUMIRADX POINT OF CARE HBA1C DEVICE
IRAS ID
280026
Contact name
Rory McCrimmon
Contact email
Sponsor organisation
LumiraDx UK Ltd
Duration of Study in the UK
0 years, 1 months, 27 days
Research summary
A performance evaluation study designed to determine whether blood samples tested for HbA1c can be accurately reported by the LumiraDx Point of Care (POC) system. The LumiraDx point of care system consists of the LumiraDx Platform, an in vitro diagnostic instrument, used with single use LumiraDx HbA1c Test Strips. The intended use of the test is as an aid in the the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.
REC name
London - Chelsea Research Ethics Committee
REC reference
20/PR/0216
Date of REC Opinion
25 Aug 2020
REC opinion
Further Information Favourable Opinion